Opicinumab
- Generic Name
- Opicinumab
- Drug Type
- Biotech
- CAS Number
- 1422268-07-2
- Unique Ingredient Identifier
- WX1WTN0Y15
- Background
Opicinumab is under investigation in clinical trial NCT02641041 (Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath